Forcura, an intelligent workflow management company, and Medalogix, a clinical decision support company, have announced their merger, creating a powerful new post-acute care technology platform. Backed by Berkshire Partners as the majority owner and The Vistria Group as the largest minority shareholder, this strategic combination aims to enhance patient care and streamline operations for home-based care providers and the broader healthcare continuum.

By joining forces, Forcura and Medalogix will offer a unified platform that simplifies patient care transitions, fosters seamless collaboration among care teams, optimizes resource allocation, and improves end-of-life care management. Leveraging artificial intelligence (AI), the merged company’s solutions will enhance transparency for referral sources and payers, refine patient care delivery, improve outcomes, and drive business performance for post-acute care providers and their partners.

The post-acute care sector, a critical component of the U.S. healthcare system, often suffers from fragmentation and siloed operations, creating challenges for both patients and providers. This merger aims to address these issues by better connecting post-acute care providers within the broader healthcare ecosystem, promoting more equitable reimbursements, and supporting the ongoing shift toward value-based care. Financial details of the transaction were not disclosed. Kirkland & Ellis LLP served as legal counsel to Forcura and Accel KKR, with Houlihan Lokey acting as the exclusive financial advisor. Ropes & Gray LLP provided legal counsel to Medalogix and Vistria, while William Blair served as their exclusive financial advisor.